Guggenheim analyst Joseph Osha maintains Generac Hldgs (NYSE:GNRC) with a Buy and lowers the price target from $561 to $455.
Merck Makes $290M Bet On Prostate Cancer Candidate
Merck & Co Inc (NASDAQ:MRK) and Orion Corporation announced a global development and commercialization agreement for Orion’s ODM-208 and other drugs targeting cytochrome…